Heterocyclic indanone potentiators of metabotropic glutamate receptors

Details for Australian Patent Application No. 2005299797 (hide)

Owner Merck & Co., Inc.

Inventors Cube, Rowena V.; Pinkerton, Anthony B.; Hutchinson, John H.; Vernier, JeanMichel

Agent Spruson & Ferguson

Pub. Number AU-A-2005299797

PCT Pub. Number WO2006/047237

Priority 60/621,699 25.10.04 US

Filing date 21 October 2005

Wipo publication date 4 May 2006

International Classifications

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 213/70 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Event Publications

26 April 2007 PCT application entered the National Phase

  PCT publication WO2006/047237 Priority application(s): WO2006/047237

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299802-Duffy antigen receptor for chemokines and use thereof

2005299794-Vertically aligning slackless drawbar